Contracts › 36C26126F0168
36C26126F0168: Pluvicto - Lutetium Lu 177 Vipivotide Tetra 27MCI/Ml
Awarded to Novartis Pharmaceuticals Corporation by Department of Veterans Affairs.
$1.2Mobligated
$2.4Mpotential value
30 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 36C26126F0168 |
|---|---|
| Vehicle | 36F79720D0180 |
| Awardee | Novartis Pharmaceuticals Corporation |
| Awarding agency | Department of Veterans Affairs |
| Awarding office | 261-NETWORK CONTRACT OFFICE 21 (36C261) |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 01 April 2026 to 30 September 2026 |
| Potential end | 30 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record